Skip to content
Unrated Drug recall · FDA · Published September 19, 2013

Ferring Recalls Endometrin Vaginal Inserts Due to Discoloration

Ferring Pharmaceuticals recalls specific lots of Endometrin vaginal inserts due to discoloration from heat exposure. Check your lot numbers.

🇺🇸 FDA recall #D-1426-2014DrugFerring Pharmaceuticals ›
Take action

Contact the company

Recalling firmFerring Pharmaceuticals Inc4 Gatehall Dr Fl 3rd · Parsippany, NJ 07054-4518
✎ GovInfoNow plain-language explainer

Ferring Pharmaceuticals Inc is recalling specific lots of Endometrin (progesterone) Vaginal Insert 100 mg USP because the product has become discolored due to prolonged heat exposure. The recall affects 72,046 cartons distributed nationwide. The record does not specify what consumers should do with the affected product. Read more at govinfonow.com/recall/46590-ferring-pharmaceuticals-inc-recalls-endometrin-progesterone-vaginal-insert-100-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/46590-ferring-pharmaceuticals-inc-recalls-endometrin-progesterone-vaginal-insert-100-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-1426-2014

Cite this page

“Ferring Recalls Endometrin Vaginal Inserts Due to Discoloration.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46590-ferring-pharmaceuticals-inc-recalls-endometrin-progesterone-vaginal-insert-100-mg. Based on FDA recall #D-1426-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1426-2014%22&limit=1).

Ferring Pharmaceuticals Inc voluntarily recalled Endometrin Vaginal Insert 100 mg USP due to discoloration from prolonged heat exposure, according to a Food and Drug Administration announcement on Sept. 19, 2013.

How to tell if you have it

  • Brand: Ferring Pharmaceuticals
  • Product: Endometrin Vaginal Insert
  • NDC: 55566-6500-3
  • Lot Numbers: 0804.182B-1, 0804.183B-1, 0804.185A-1, 0804.186B-1, 0804.187B-1, 0804.210A-1, 0804.212A-1, 0804.213A-1, 0804.214A-1, 0804.216B-1, 0804.223B-1, 0804.225B-1
  • Distribution: Nationwide

The hazard

The recall addresses discoloration caused by prolonged heat exposure, according to the FDA.

Context

GovInfoNow's records show Ferring Pharmaceuticals Inc has 8 other recalls on record since Aug. 23, 2012. Other recent recalls of similar products include Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), Sun Pharmaceutical Fexofenadine 180mg Tablets Recall (June 1, 2026), and Asteria Health ESTRADIOL 20mg Pellet Recall (Jan. 26, 2026).

How to tell if you have this one

Look for Endometrin (progesterone) Vaginal Insert 100 mg USP, Rx Only, manufactured for Ferring Pharmaceuticals Inc. Check if your product has one of these lot numbers: 0804.182B-1, 0804.183B-1, 0804.185A-1, 0804.186B-1, 0804.187B-1, 0804.210A-1, 0804.212A-1, 0804.213A-1, 0804.214A-1, 0804.216B-1, 0804.223B-1, or 0804.225B-1.

  • Brand
    Ferring Pharmaceuticals
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Sep 19, 201312. FDA classified it Class III: Jul 9, 201423. Published in FDA’s Enforcement Report: Jul 16, 201434. FDA terminated the recall: Feb 19, 2015420132015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1426-2014 (September 19, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1426-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA